Koonin, E. V., Wolf, Y. I. & Katsnelson, M. I. Inevitability of the emergence and persistence of genetic parasites caused by evolutionary instability of parasite-free states. Biol. Direct 12, 1–12 (2017).
Frost, L. S., Leplae, R., Summers, A. O. & Toussaint, A. Mobile genetic elements: The agents of open source evolution. Nat. Rev. Microbiol. 3, 722–732 (2005).
CAS PubMed Article Google Scholar
Van Valen, L. A new evolutionary law. Evol. Theory 1, 1–30 (1973).
Koonin, E. V. Viruses and mobile elements as drivers of evolutionary transitions. Philos. Trans. R. Soc. B Biol. Sci. 371, 20150442 (2016).
Bernheim, A. & Sorek, R. The pan-immune system of bacteria: antiviral defence as a community resource. Nat. Rev. Microbiol. 18, 113–119 (2020).
CAS PubMed Article Google Scholar
Tesson, F. et al. Systematic and quantitative view of the antiviral arsenal of prokaryotes. Nat. Commun. 13, 2561 (2022).
CAS PubMed PubMed Central Article Google Scholar
Rocha, E. P. C. & Bikard, D. Microbial defenses against mobile genetic elements and viruses: who defends whom from what? PLoS Biol. 20, e3001514 (2022).
CAS PubMed PubMed Central Article Google Scholar
Hampton, H. G., Watson, B. N. J. & Fineran, P. C. The arms race between bacteria and their phage foes. Nature 577, 327–336 (2020).
CAS PubMed Article Google Scholar
Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 (2007).
CAS PubMed Article Google Scholar
Deveau, H. et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190, 1390–1400 (2008).
CAS PubMed Article Google Scholar
Barrangou, R. & Horvath, P. A decade of discovery: CRISPR functions and applications. Nat. Microbiol. 2, 17092 (2017).
CAS PubMed Article Google Scholar
Datsenko, K. A. et al. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun. 3, 1–7 (2012).
Swarts, D. C., Mosterd, C., van Passel, M. W. J. & Brouns, S. J. J. CRISPR interference directs strand specific spacer acquisition. PLoS ONE 7, e35888 (2012).
CAS PubMed PubMed Central Article Google Scholar
Nussenzweig, P. M., McGinn, J. & Marraffini, L. A. Cas9 cleavage of viral genomes primes the acquisition of new immunological memories. Cell Host Microbe 26, 515–526.e6 (2019).
CAS PubMed PubMed Central Article Google Scholar
Carte, J., Wang, R., Li, H., Terns, R. M. & Terns, M. P. Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev. 22, 3489–3496 (2008).
CAS PubMed PubMed Central Article Google Scholar
East-Seletsky, A. et al. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature 538, 270–273 (2016).
CAS PubMed PubMed Central Article Google Scholar
Brouns, S. J. J. et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321, 960–964 (2008).
CAS PubMed PubMed Central Article Google Scholar
Hille, F. et al. The biology of CRISPR-Cas: backward and forward. Cell 172, 1239–1259 (2018).
CAS PubMed Article Google Scholar
Bernheim, A., Bikard, D., Touchon, M. & Rocha, E. P. C. Atypical organizations and epistatic interactions of CRISPRs and cas clusters in genomes and their mobile genetic elements. Nucleic Acids Res. 48, 748–760 (2020).
Jia, N. & Patel, D. J. Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins. Nat. Rev. Mol. Cell Biol. 22, 563–579 (2021).
CAS PubMed Article Google Scholar
Wilkinson, M. et al. Structural basis for the inhibition of RecBCD by Gam and its synergistic antibacterial effect with quinolones. Elife 5, 1–12 (2016).
Shah, M. et al. A phage-encoded anti-activator inhibits quorum sensing in Pseudomonas aeruginosa. Mol. Cell 81, 571–583.e6 (2021).
CAS PubMed Article Google Scholar
Bandyopadhyay, P. K., Studier, F. W., Hamilton, D. L. & Yuan, R. Inhibition of the type I restriction-modification enzymes EcoB and EcoK by the gene 0.3 protein of bacteriophage T7. J. Mol. Biol. 182, 567–578 (1985).
CAS PubMed Article Google Scholar
Deveau, H., Garneau, J. E. & Moineau, S. CRISPR/Cas system and its role in phage-bacteria interactions. Annu. Rev. Microbiol. 64, 475–493 (2010).
CAS PubMed Article Google Scholar
Hutinet, G., Lee, Y., de Crécy-lagard, V. & Weigele, P. R. Hypermodified DNA in viruses of E. coli and Salmonella. EcoSalPlus 9, eESP00282019 (2021).
Bryson, A. L. et al. Covalent modification of bacteriophage T4 DNA inhibits CRISPRCas9. mBio https://doi.org/10.1128/mBio.00648-15 (2015).
Article PubMed PubMed Central Google Scholar
Vlot, M. et al. Bacteriophage DNA glucosylation impairs target DNA binding by type I and II but not by type V CRISPR–Cas effector complexes. Nucleic Acids Res. 46, 873–885 (2018).
CAS PubMed Article Google Scholar
Mendoza, S. D. et al. A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases. Nature 577, 244–248 (2020).
CAS PubMed Article Google Scholar
Malone, L. M. et al. A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity. Nat. Microbiol. 5, 48–55 (2020).
CAS PubMed Article Google Scholar
Jiang, W., Samai, P. & Marraffini, L. A. Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR-Cas immunity. Cell 164, 710–721 (2016).
CAS PubMed PubMed Central Article Google Scholar
Lopatina, A., Tal, N. & Sorek, R. Abortive infection: bacterial suicide as an antiviral immune strategy. Annu. Rev. Virol. 7, 371–384 (2020).
CAS PubMed Article Google Scholar
Neri, U. et al. A five-fold expansion of the global RNA virome reveals multiple new clades of RNA bacteriophages. bioRxiv https://doi.org/10.1101/2022.02.15.480533 (2022).
Wolf, Y. I. et al. Doubling of the known set of RNA viruses by metagenomic analysis of an aquatic virome. Nat. Microbiol. 5, 1262–1270 (2020).
CAS PubMed PubMed Central Article Google Scholar
Artamonova, D. et al. Spacer acquisition by type III CRISPR–Cas system during bacteriophage infection of Thermus thermophilus. Nucleic Acids Res. 48, 9787–9803 (2020).
CAS PubMed PubMed Central Article Google Scholar
Maniv, I., Jiang, W., Bikard, D. & Marraffini, L. A. Impact of different target sequences on type III CRISPR-Cas immunity. J. Bacteriol. 198, 941–950 (2016).
CAS PubMed PubMed Central Article Google Scholar
Manica, A., Zebec, Z., Steinkellner, J. & Schleper, C. Unexpectedly broad target recognition of the CRISPR-mediated virus defence system in the archaeon Sulfolobus solfataricus. Nucleic Acids Res. 41, 10509–10517 (2013).
CAS PubMed PubMed Central Article Google Scholar
Johnson, K., Learn, B. A., Estrella, M. A. & Bailey, S. Target sequence requirements of a type III-B CRISPR-Cas immune system. J. Biol. Chem. 294, 10290–10299 (2019).
CAS PubMed PubMed Central Article Google Scholar
Pyenson, N. C., Gayvert, K., Varble, A., Elemento, O. & Marraffini, L. A. Broad targeting specificity during bacterial type III CRISPR-Cas immunity constrains viral escape. Cell Host Microbe 22, 343–353.e3 (2017).
CAS PubMed PubMed Central Article Google Scholar
Gleditzsch, D. et al. PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures. RNA Biol. 16, 504–517 (2019).
Meeske, A. J. & Marraffini, L. A. RNA guide complementarity prevents self-targeting in type VI CRISPR systems. Mol. Cell 71, 791–801.e3 (2018).
留言 (0)